Mitsubishi UFJ Trust & Banking’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.2M | Buy |
84,348
+19,254
| +30% | +$3.68M | 0.04% | 371 |
|
|
2026
Q1 | $11.9M | Sell |
65,094
-224
| -0.3% | -$41.3K | 0.03% | 466 |
|
|
2025
Q4 | $11.5M | Sell |
65,318
-19,342
| -23% | -$3.16M | 0.03% | 491 |
|
|
2025
Q3 | $11.9M | Buy |
84,660
+3,465
| +4% | +$468K | 0.03% | 518 |
|
|
2025
Q2 | $10.2M | Buy |
81,195
+3,962
| +5% | +$494K | 0.02% | 540 |
|
|
2025
Q1 | $10.6M | Sell |
77,233
-4,381
| -5% | -$626K | 0.03% | 522 |
|
|
2024
Q4 | $12.5M | Buy |
81,614
+2,443
| +3% | +$412K | 0.03% | 526 |
|
|
2024
Q3 | $15.3M | Buy |
79,171
+544
| +0.7% | +$114K | 0.04% | 479 |
|
|
2024
Q2 | $18.2M | Buy |
78,627
+574
| +0.7% | +$125K | 0.04% | 398 |
|
|
2024
Q1 | $16.8M | Sell |
78,053
-6,254
| -7% | -$1.46M | 0.04% | 441 |
|
|
2023
Q4 | $21.8M | Sell |
84,307
-12,466
| -13% | -$3.06M | 0.05% | 365 |
|
|
2023
Q3 | $24.9M | Sell |
96,773
-1,219
| -1% | -$326K | 0.06% | 327 |
|
|
2023
Q2 | $27.9M | Sell |
97,992
-30,202
| -24% | -$8.99M | 0.06% | 322 |
|
|
2023
Q1 | $35.6M | Sell |
128,194
-28,381
| -18% | -$7.85M | 0.09% | 260 |
|
|
2022
Q4 | $43.4M | Sell |
156,575
-13,721
| -8% | -$3.88M | 0.11% | 201 |
|
|
2022
Q3 | $45.5M | Buy |
170,296
+5,713
| +3% | +$1.21M | 0.13% | 174 |
|
|
2022
Q2 | $33.6M | Buy |
164,583
+11,432
| +7% | +$2.34M | 0.09% | 245 |
|
|
2022
Q1 | $32.3M | Sell |
153,151
-8,630
| -5% | -$1.88M | 0.07% | 269 |
|
|
2021
Q4 | $38.8M | Sell |
161,781
-24,082
| -13% | -$6.19M | 0.08% | 259 |
|
|
2021
Q3 | $52.6M | Sell |
185,863
-14,872
| -7% | -$4.87M | 0.11% | 206 |
|
|
2021
Q2 | $69.5M | Sell |
200,735
-26,316
| -12% | -$7.97M | 0.15% | 165 |
|
|
2021
Q1 | $59.6M | Sell |
227,051
-4,253
| -2% | -$1.15M | 0.13% | 196 |
|
|
2020
Q4 | $56.6M | Buy |
231,304
+128
| +0.1% | +$33K | 0.11% | 215 |
|
|
2020
Q3 | $65.6M | Buy |
231,176
+6,266
| +3% | +$1.75M | 0.15% | 164 |
|
|
2020
Q2 | $60.2M | Buy |
224,910
+7,661
| +4% | +$2.3M | 0.15% | 166 |
|
|
2020
Q1 | $68.7M | Buy |
217,249
+9,623
| +5% | +$2.92M | 0.2% | 121 |
|
|
2019
Q4 | $61.6M | Buy |
207,626
+2,521
| +1% | +$699K | 0.15% | 149 |
|
|
2019
Q3 | $47.3M | Buy |
205,105
+22,661
| +12% | +$5.28M | 0.12% | 193 |
|
|
2019
Q2 | $43.7M | Buy |
182,444
+5,420
| +3% | +$1.25M | 0.15% | 150 |
|
|
2019
Q1 | $41.2M | Sell |
177,024
-1,469
| -0.8% | -$463K | 0.15% | 145 |
|
|
2018
Q4 | $53.7M | Buy |
178,493
+377
| +0.2% | +$120K | 0.22% | 102 |
|
|
2018
Q3 | $62.9M | Sell |
178,116
-267,822
| -60% | -$92.2M | 0.22% | 105 |
|
|
2018
Q2 | $129M | Buy |
445,938
+8,073
| +2% | +$2.27M | 0.22% | 99 |
|
|
2018
Q1 | $120M | Buy |
437,865
+4,009
| +0.9% | +$1.24M | 0.21% | 110 |
|
|
2017
Q4 | $138M | Sell |
433,856
-11,609
| -3% | -$3.72M | 0.24% | 93 |
|
|
2017
Q3 | $139M | Sell |
445,465
-5,151
| -1% | -$1.53M | 0.26% | 92 |
|
|
2017
Q2 | $122M | Sell |
450,616
-37,414
| -8% | -$9.89M | 0.24% | 100 |
|
|
2017
Q1 | $133M | Buy |
488,030
+14,320
| +3% | +$4.05M | 0.27% | 84 |
|
|
2016
Q4 | $134M | Sell |
473,710
-9,567
| -2% | -$2.84M | 0.28% | 80 |
|
|
2016
Q3 | $151M | Sell |
483,277
-27,559
| -5% | -$8.16M | 0.31% | 73 |
|
|
2016
Q2 | $124M | Sell |
510,836
-4,731
| -0.9% | -$1.25M | 0.27% | 88 |
|
|
2016
Q1 | $134M | Buy |
515,567
+13,617
| +3% | +$3.6M | 0.3% | 76 |
|
|
2015
Q4 | $154M | Buy |
501,950
+36,004
| +8% | +$10.3M | 0.35% | 65 |
|
|
2015
Q3 | $136M | Buy |
465,946
+7,423
| +2% | +$2.45M | 0.33% | 65 |
|
|
2015
Q2 | $185M | Buy |
458,523
+3,797
| +0.8% | +$1.52M | 0.42% | 50 |
|
|
2015
Q1 | $192M | Buy |
454,726
+14,628
| +3% | +$5.77M | 0.45% | 49 |
|
|
2014
Q4 | $149M | Buy |
440,098
+12,761
| +3% | +$4.13M | 0.35% | 63 |
|
|
2014
Q3 | $141M | Sell |
427,337
-18,397
| -4% | -$6.07M | 0.34% | 65 |
|
|
2014
Q2 | $141M | Buy |
445,734
+3,699
| +0.8% | +$1.11M | 0.32% | 68 |
|
|
2014
Q1 | $135M | Buy |
442,035
+340
| +0.1% | +$108K | 0.33% | 64 |
|
|
2013
Q4 | $123M | Sell |
441,695
-8,873
| -2% | -$2.29M | 0.3% | 69 |
|
|
2013
Q3 | $108M | Buy |
450,568
+9,894
| +2% | +$2.21M | 0.29% | 81 |
|
|
2013
Q2 | $94.8M | Buy |
+440,674
| New | +$94.2M | 0.27% | 86 |
|
Other funds holding BIIB
Mitsubishi UFJ Trust & Banking's BIIB Position: Q2 2026 in Review
Mitsubishi UFJ Trust & Banking increased its Biogen (BIIB) stake by 30% in Q2 2026, buying an estimated $3.68M and bringing the position to 84,348 shares worth $18.2M. The position accounts for 0.04% of the portfolio, ranked #371.
Mitsubishi UFJ Trust & Banking first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $192M in Q1 2015. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Mitsubishi UFJ Trust & Banking held 84,348 shares of Biogen worth $18.2M as of Q2 2026.
- Mitsubishi UFJ Trust & Banking bought 19,254 Biogen shares in Q2 2026, an estimated $3.68M.
- Biogen made up 0.04% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #371 holding.
- Mitsubishi UFJ Trust & Banking first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Mitsubishi UFJ Trust & Banking's Biogen position peaked at $192M in Q1 2015.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.